MELISSA GARCIA: Open Payments
NPI 1609487222 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 77 payments from 29 companies in 2025. Trend: 2023 $4,715 · 2024 $3,362 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $297 |
| GlaxoSmithKline, LLC. | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $100 |
| Inspire Medical Systems, Inc. | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $61 |
| SCILEX PHARMACEUTICALS INC. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Amgen Inc. | 3 | $52 |
Products named: VRAYLAR, LINZESS, REXULTI, RELISTOR, INSPIRE, TRELEGY ELLIPTA, JARDIANCE, JOURNAVX.
Industry payments across TX — which companies pay providers there.
